Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ...

BMS will co-develop and co-commercialize BioNTech’s bispecific antibody BNT327 for solid tumors in a deal worth up to $11.1B ...

Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ...

A new study has shown that person-to-person variation in antibody immunity plays a key role in shaping which influenza (flu) ...

Results from three trials continue to demonstrate the potential of DATROWAY® (datopotamab deruxtecan) in combination with ...

Agenus, which has been going through a reorganization after the FDA put the brakes on the biotech's regulatory plan for its ...

Here we report on the optimization of two FLT3 antibodies using recombinant antibody technology. Initially, we considered two different strategies for optimization of the Fc part: modifications of ...

Two-Part Dose Escalation and Expansion Trial Will Evaluate Efficacy and Safety of BYON4228 Alone and in Combination with Pembrolizumab NIJMEGEN, The ...

Radionuclide therapy with the radioactive element terbium could effectively combat lymphoma. This is demonstrated by ...

Merck & Co. has posted phase 2 data on zilovertamab vedotin in lymphoma, providing more evidence of the narrow safety and ...

US pharma major Bristol Myers Squibb (NYSE: BMY) has entered into an agreement for the global co-development and ...

What are the best stocks right now for investors in the cancer drug development space? Seeking Alpha analysts offer their ...